Crinetics Pharmaceuticals, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Crinetics Pharmaceuticals, Inc. (CRNX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $43.40 million as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2022-03-30
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $43.40M.
- 2021-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $44.80M.
- 2021-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $39.90M.
- 2021-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $41.20M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2021-12-31 | $43.40M 10-K · filed 2022-03-30 |
| 2021-09-30 | $44.80M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $39.90M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $41.20M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $26.90M 10-K · filed 2021-03-30 |
| 2020-09-30 | $27.40M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $26.90M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $27.60M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $17.70M 10-K · filed 2020-03-09 |
| 2019-09-30 | $19.00M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $20.00M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $19.30M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $7.90M 10-K · filed 2019-03-13 |
| 2018-09-30 | $7.70M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $7.10M 10-Q · filed 2018-08-30 |